Contents
Contents
In the Zoll Medical country origin settlement, Zoll agreed to pay $400,000 to resolve allegations that it knowingly sold Chinese-made ECG cables to federal buyers and represented replacement cables as American-made. If you work in sourcing, sales or compliance, you may recognize the gap between what a company knows about a part and what its government customer is told.
Zoll Medical Corporation supplies medical devices and related technology from its headquarters in Chelmsford, Massachusetts. The Justice Department announced the settlement on May 17, 2023. A whistleblower, a former employee, brought the allegations to the government.
The government alleged that Zoll sold Chinese-made electrocardiogram cables to federal purchasers, including the Department of Defense, between January 2019 and November 2022. The cables were used with defibrillators and cardiac monitors.
In its account of the case, the Justice Department explained that the Trade Agreements Act required goods sold to these government purchasers to be made in the United States or certain designated foreign countries. China was outside that group. The government’s allegation was that Zoll knew where the cables had been manufactured and sold them to federal buyers anyway.
Here, the federal agency was itself the buyer. The company’s representation went to government officials deciding what the government would purchase.
The alleged mismatch therefore sat in the sale: Chinese manufacture on the supply side, American manufacture in the account given to the customer. Taxpayers were paying for goods subject to a purchasing condition that, according to the government, the cables did not meet.
The government specifically alleged that Zoll told officials in January 2019 that replacement ECG cables offered to federal purchasers had been manufactured in the United States. According to the allegation, those cables had actually been made in China.
An employee who knew the source could compare that assurance with the product information inside the business, including who had the manufacturing information when the representation went to officials.
The whistleblower, a former Zoll employee, filed a qui tam complaint on behalf of the United States alleging that the company violated the False Claims Act. The Justice Department said that the whistleblower brought the allegations to the government’s attention and that the settlement followed an extensive investigation.
Investigators from the Food and Drug Administration and the military worked on the case alongside the inspectors general for Veterans Affairs and Health and Human Services.
The government settled claims for payment by mistake and breach of contract. The whistleblower had brought a False Claims Act case, and the government used those payment and contract claims to resolve the conduct. The origin allegations still led to an agreement requiring Zoll to pay the federal government.
The 2020 Journal of Forensic and Investigative Accounting paper A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud explains payment by mistake: it lets the government recover money paid by mistake to a recipient who had no right to keep it. In Zoll’s case, the alleged mistake concerned the manufacturing origin of the goods the government bought.
For an insider, the useful contribution is knowledge of the transaction. We work with whistleblower lawyers to assess how those facts support a recovery.
Medtronic’s country-of-origin settlement concerned alleged false origin representations in medical-device sales to the Department of Veterans Affairs and the Department of Defense. Announced on April 2, 2015, that settlement required Medtronic to pay $4.41 million.
The allegations concerned devices manufactured in China and Malaysia and conduct from 2007 through 2014. The recurring issue is the same one a procurement or sourcing employee would recognize in the Zoll case: the country represented to a federal buyer and the country where the product was made.
An origin representation can determine whether a government purchase meets its requirements independently of the device’s clinical performance. The factory information becomes part of the purchasing decision. That is why an employee with knowledge of manufacturing or federal sales can have something consequential to contribute to a medical-device case.
For an origin case like Zoll’s, we examine evidence connecting the product’s manufacture, the representation to the federal buyer, the purchase and what the supplier knew. We compare the manufacturing information behind the particular part with the assurance given to officials and the federal sales it covered.
Different employees may know different parts of that account. A sourcing employee may know where the cable came from. A sales employee may know what officials were told. A procurement or compliance employee may understand the origin condition attached to the sale. We work with the insider to connect those facts to the same product and transaction.
You may know who had the manufacturing information, how the origin representation reached the buyer, or which purchases it concerned. We assess those connections with you and bring in whistleblower lawyers who understand federal procurement and medical-device sales.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If the manufacturing information you know conflicts with what a federal customer was told, speak with our whistleblower experts. We build the case with you around the product, the government’s purchase and the decisions inside the supplier, and bring in federal-procurement whistleblower lawyers who understand medical-device cases. We stay beside you through the pursuit of the government’s recovery.